The UK’s NICE Recommends GSK’s €594000 Gene Therapy – Labiotech.eu (blog)
Labiotech.eu (blog) |
The UK's NICE Recommends GSK's €594000 Gene Therapy
Labiotech.eu (blog) Amidst uncertainty about the commercial future of expensive gene therapies, the UK's NICE has declared GSK's Strimvelis offers “value for money.” Approved by the EMA last year, Strimvelis is one of the most expensive drugs on the market. Although GSK … |
